Abstract
Interspecies somatic cell hybrids were generated by fusing the mouse T-lymphoma cell line, BW5147, with normal human T lymphocytes at different stages of differentiation. Thymocytes, activated peripheral T lymphocytes, or an activated T-cell clone were used as human partners, respectively, in three independent fusions. Irrespective of the human cell partner used for fusion, a certain number of hybrids lost CD5 surface expression over a period of time in culture. Analysis at the phenotype and genetic level showed that lack of CD5 expression was due neither to segregation of human autosome 11, on which the CD5 gene has been mapped, nor to deletion of the CD5 structural gene. Furthermore, loss of CD5 surface expression correlated with the absence of specific mRNA. Since these hybrids preferentially segregate human chromosomes, these results indicate the existence of a non-syntenic trans-active locus, or loci, positively controlling the expression of the human CD5 gene.
Similar content being viewed by others
References
Accolla, R. S., Dellabona, P., Scarpellino, L., Carra, G., and Sartoris, S. A family of trans-acting factors with distinct regulatory functions control expression of MHC class II genes. Immunol Res 9: 20–33, 1990
Ala-Kapee, U., Forsberg, H., Jalkanen, S., and Schroder, J. Mapping of gene for human lymphocyte homing receptor to the short arm of chromosome 11. Cytogenet Cell Genet 51: HGM10 A2660, 1989
Alberola-Ila, J., Places, L., Cantrell, D. A., Vives, J., and Lozano, F. Intracellular events involved in CD5-induced human T cell activation and proliferation. J Immunol 148: 1287–1293, 1992
Burgess, K. E., Yamamoto, M., Prasad, K. V. S., and Rudd, C. E. CD5 acts as a tyrosine kinase substrate within a receptor complex comprising T-cell receptor ζ chain/CD3 and protein-tyrosine kinases p56lck and p59fyn. Proc Natl Acad Sci USA 89: 9311–9315, 1992
Cambiaggi, C., Scupoli, M. T., Cestari, T., Gerosa, F., Carra, G., Tridente, G., and Accolla, R. S. Constitutive expression of CD69 in interspecies T-cell hybrids and locus assignment to human chromosome 12. Immunogenetics 36: 117–120, 1992
Ceuppens, J. L. and Baroja, M. L. Monoclonal antibodies to the CD5 antigen can provide the necessary second signal for activation of isolated resting T cells solid-phase-bound OKT3. J Immunol 37: 1816–1821, 1986
Chiron, M., Darbon, J. M., Roubinet, F., Cassar, G., Jaffrezou, J. P., Bordier, C., and Laurent, G. Quantitative analysis of CD5 antigen modulation by 12-O-tetradecanoylphorbol-13-acetate in T-lymphoblastic leukemia cells: individual response patterns and their relationships with both maturation and protein kinase C content. Cell Immunol 130: 339–351, 1990
Davies, A. A., Ley, S. C., Crumpton, M. J. CD5 is phosphorylated on tyrosine after stimulation of the T-cell antigen receptor-complex. Proc Natl Acad Sci USA 89: 6368–6372, 1992
Engleman, E. G., Warnke, R., Fox, R. I., Dilley, J., Benike, C. J., Levy, R. Studies of a human T lymphocyte antigenrecognized by a monoclonal antibody. Proc Nat Acad Sci USA 78: 1791–1795, 1981
Hardin, J. A., Gibson, M., Kawano, Y., Spielberg, S., Martin, C., Collins, M., Dorf, M. E., and Sherr, D. H. Characterization of a B cell helper factor(s) derived from CD5+ B cell hybridomas. Cell Immunol 126: 304–321, 1990
Hardy, R. R., Hayakawa, K. Development and physiology of LY-1 B and its human homolog, LEU-1 B. Immunol Rev 93: 53–79, 1986
Hecht, B. K., Kipps, T., Johnston, N. K., and Cannizzaro, A. Leu 1 (CD5) cell surface antigen mapped to 11q13 by in situ hybridization. Cytogenet Cell Genet 51: HGM10 A2538, 1989
Huang, H.-J. S., Jones, N. H., Strominger, J. L., Herzenberg, L. A. Molecular cloning of Ly-1, a membrane glycoprotein of mouse T lymphocytes and a subset of B cells: molecular homology to its human counterpart Leu-1/T1(CD5). Proc Natl Acad Sci USA 84: 204–208, 1987
Jones, N. H., Clabby, M. L., Dialynas, D. P., Huang, H.-J. S., Herzenberg, L. A., and Strominger, J. L. Isolation of complementary DNA clones encoding the human lymphocyte glycoprotein T1/Leu-1. Nature 323: 346–349, 1986
Kantor, A. B. The development and repertoire of B-1 cells (CD5 B cells). Immunol Today 12: 389–391, 1991
Kawamura, N., Muraguchi, A., Horii, Y., Matsuura, S., Hardy, R. R., Kikutani, H., and Kishimoto, T. A case of human B cell leukemia that implicates an autocrine mechanism in the abnormal growth of Leu 1 B cells. J Clin Invest 78: 1331–1338, 1986
Maniatis, T., Fritsch, E., and Sambrook, J. Molecular Cloning: A Laboratory Manual. Cold Spring Harbour Laboratory, Cold Spring Harbour, 1982
Ramarli, D., Cambiaggi, C., De Giuli Morghen, C., Tripputi, P., Ortolani, R., Bolzanelli, M., Tridente, G., and Accolla, R. S. Susceptibility of human-mouse T cell hybrids to HIV productive infection. AIDS Res Hum Retroviruses 9: 1263–1269, 1993
Reinherz, E. L., Kung, P. C., Goldstein, G., and Schlossman, S. F. A monoclonal antibody with selective reactivity with functionally mature human thymocytes and all peripheral human T cells. J. Imuunol 123: 1312–1317, 1979
Spertini, F., Stohl, W., Ramesh, N., Moody, C., and Geha, R. S. Induction of human T cell proliferation bya monoclonal antibody to CD5. J Immunol 146: 47–52, 1991
Subbarao, B., Mosier, D. E. Induction of B lymphocytes proliferation by monoclonal anti-Lyb 2 antibody. J Immunol 130: 2033–2037, 1983
Van de Velde, H., von Hoegen, I., Lyuo, W., Parnes, J. R., and Thielemans, K. The B-cell surface protein CD72/Lyb-2 is the ligand for CD5. Nature 351: 662–665, 1991
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Scupoli, M.T., Sartoris, S., Nicolis, M. et al. Evidence for a trans-acting activator function regulating the expression of the human CD5 antigen. Immunogenetics 40, 217–221 (1994). https://doi.org/10.1007/BF00167082
Received:
Revised:
Issue Date:
DOI: https://doi.org/10.1007/BF00167082